Literature DB >> 19290628

Bovine milk caseins and transglutaminase-treated cereal prolamins are differentially recognized by IgA of celiac disease patients according to their age.

Francisco Cabrera-Chávez1, Ofelia Rouzaud-Sández, Norberto Sotelo-Cruz, Ana M Calderón de la Barca.   

Abstract

The prevalence of celiac disease (CD) has increased worldwide, which could be related to some dietary proteins in infant regimens and/or new food processes, affecting CD-predisposed infants and older children or adults differentially. IgA reactivity to human and bovine caseins, as well as yogurt caseins and prolamins from wheat or maize breads, microbial transglutaminase (mTG)-treated or not, was evaluated in three patient groups: G1, <2 years old; G2, approximately 3 years old; and G3 >8 years old. Human caseins were not recognized by IgA, whereas IgA reactivity of G2 and G3 was higher to bovine milk caseins. Immunoreactivity of G1 to yogurt caseins was lower and comparable to controls, with no effects due to mTG treatment. However, mTG treatment increased reactivity of G3 to wheat and maize prolamins. IgA immunoreactivity of CD patients to caseins and mTG-treated or not prolamins was age-dependent, which could reflect a differential manifestation of the effects of such proteins on the intestinal barrier.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19290628     DOI: 10.1021/jf802596g

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  7 in total

1.  Maize prolamins resistant to peptic-tryptic digestion maintain immune-recognition by IgA from some celiac disease patients.

Authors:  Francisco Cabrera-Chávez; Stefania Iametti; Matteo Miriani; Ana M Calderón de la Barca; Gianfranco Mamone; Francesco Bonomi
Journal:  Plant Foods Hum Nutr       Date:  2012-03       Impact factor: 3.921

2.  Enteric parasitic infection disturbs bacterial structure in Mexican children with autoantibodies for type 1 diabetes and/or celiac disease.

Authors:  Ana M Calderón de la Barca; Reyna S Castillo-Fimbres; María Esther Mejía-León; Luis Quihui-Cota; Adrián Ochoa-Leyva; Sandra V Aguayo-Patrón
Journal:  Gut Pathog       Date:  2020-08-11       Impact factor: 4.181

Review 3.  Celiac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

4.  Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis.

Authors:  Aaron Lerner; Torsten Matthias
Journal:  Nutr Rev       Date:  2015-06-16       Impact factor: 7.110

Review 5.  Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients.

Authors:  Juan P Ortiz-Sánchez; Francisco Cabrera-Chávez; Ana M Calderón de la Barca
Journal:  Nutrients       Date:  2013-10-21       Impact factor: 5.717

Review 6.  Processed Food Additive Microbial Transglutaminase and Its Cross-Linked Gliadin Complexes Are Potential Public Health Concerns in Celiac Disease.

Authors:  Aaron Lerner; Torsten Matthias
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

7.  The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice.

Authors:  Feng Li; Yan Chen; Shubo Liu; Xue Pan; Yulan Liu; Huiting Zhao; Xiujing Yin; Chunlin Yu; Wei Kong; Yong Zhang
Journal:  Int J Nanomedicine       Date:  2019-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.